Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa
Health

IDEAYA Biosciences announces first patient dosed in Phase 1 IDE849 and IDE161 combination study

IDEAYA Biosciences (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the first-patient-in (FPI) for its Phase 1 clinical trial evaluating the combination of IDE849 and IDE161.

Read more: IDEAYA Biosciences announces first patient dosed in Phase 1 IDE849 and IDE161 combination study